First Time Loading...

Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 3 064 JPY -0.49% Market Closed
Updated: May 6, 2024

Rohto Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rohto Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4911
4927
4452
F
4921
4967

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Operating Income
¥40.6B
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
9%
Shiseido Co Ltd
TSE:4911
Operating Income
¥19.3B
CAGR 3-Years
9%
CAGR 5-Years
-29%
CAGR 10-Years
-9%
Pola Orbis Holdings Inc
TSE:4927
Operating Income
¥16.1B
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
0%
Kao Corp
TSE:4452
Operating Income
¥86.6B
CAGR 3-Years
-21%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
F
Fancl Corp
TSE:4921
Operating Income
¥11.5B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
14%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Operating Income
¥25.8B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
4%

See Also

What is Rohto Pharmaceutical Co Ltd's Operating Income?
Operating Income
40.6B JPY

Based on the financial report for Dec 31, 2023, Rohto Pharmaceutical Co Ltd's Operating Income amounts to 40.6B JPY.

What is Rohto Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
9%

Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Rohto Pharmaceutical Co Ltd have been 25% over the past three years , 14% over the past five years , and 9% over the past ten years .